Company / Working Capital
United Therapeutics Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$3.1B
FY2025
5-year range
$2.0B / $3.1B
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#15 of 213
Health Care
What the data says
Among 213 Health Care companies, United Therapeutics is in the top 7% for working capital. Working Capital has fluctuated over the past 10 years, ranging from $1.0B in FY2017 to $3.1B in FY2025.
Based on SEC 10-K filings.
$3.1B in FY2025 with a 5-year CAGR of +11.2%. Top quartile in the Health Care sector.
Improved from $2.7B to $3.1B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +1.1%
- 5-Year CAGR
- +11.2%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 213This company $3.1B Sector average $934.6M
▼
+236.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +11.2%, indicating consistent growth.
- In FY2025, working capital increased 0.2% year-over-year.
- Ranks #15 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.1B | +0.2% |
| FY2024 | $3.1B | +14.2% |
| FY2023 | $2.7B | -9.6% |
| FY2022 | $3.0B | +50.5% |
| FY2021 | $2.0B | +9.5% |
| FY2020 | $1.8B | +31.6% |
| FY2019 | $1.4B | -6.0% |
| FY2018 | $1.5B | +48.7% |
| FY2017 | $1.0B | -8.2% |
| FY2016 | $1.1B | +30.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026